Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

DSM staff profile

Professor Rathan Subramaniam

PositionDean
QualificationsMB BS(Melb) MClinEd(NSW) MPH(Harvard) PhD(Auck) FRANZCR FACNM

Publications

Marcus, C., & Subramaniam, R. M. (2020). Role of non-FDG-PET/CT in head and neck cancer. Seminars in Nuclear Medicine. Advance online publication. doi: 10.1053/j.semnuclmed.2020.07.008

Hurwitz, M., Buscombe, J. R., Jacene, H. A., Klitzke, A. K., Lamonica, D., Lu, Y., … Subramaniam, R. M., … Brown, R. K. J. (2020). ACR-ACNM-ASTRO-SNMMI practice parameter for the performance of therapy with radium-223. American Journal of Clinical Oncology, 43(8), 539-544. doi: 10.1097/coc.0000000000000702

Subramaniam, R. M., Kurth, D. A., Waldrip, M. H. A., & Rybicki, F. J. (2019). American College of Radiology Appropriateness Criteria: Advancing Evidence-Based Imaging Practice. Seminars in Nuclear Medicine, 49(2), 161-165. doi: 10.1053/j.semnuclmed.2018.11.011

You, H., Xi, Y., Moore, W., Sher, D., Sanli, Y., & Subramaniam, R. M. (2019). Timing and impact of posttreatment PET/CT after first 6 months on patient management and outcomes in oropharyngeal squamous cell carcinoma. American Journal of Roentgenology, 212(5), 1142-1147. doi: 10.2214/AJR.18.20619

Rahmim, A., Bak-Fredslund, K. P., Ashrafinia, S., Lu, L., Schmidtlein, C. R., Subramaniam, R. M., … Munk, O. L. (2019). Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. European Journal of Radiology, 113, 101-109. doi: 10.1016/j.ejrad.2019.02.006

Chapter in Book - Research

Gholamrezanezhad, A., Pinkus, E., & Subramaniam, R. (2013). SPECT in malignant bone diseases. In H. Ahmadzadehfar & E. Habibi (Eds.), SPECT: Technology, procedures and applications. (pp. 75-90). Hauppauge, NY: Nova Science.

^ Top of page

Journal - Research Article

Marcus, C., & Subramaniam, R. M. (2020). Role of non-FDG-PET/CT in head and neck cancer. Seminars in Nuclear Medicine. Advance online publication. doi: 10.1053/j.semnuclmed.2020.07.008

Hurwitz, M., Buscombe, J. R., Jacene, H. A., Klitzke, A. K., Lamonica, D., Lu, Y., … Subramaniam, R. M., … Brown, R. K. J. (2020). ACR-ACNM-ASTRO-SNMMI practice parameter for the performance of therapy with radium-223. American Journal of Clinical Oncology, 43(8), 539-544. doi: 10.1097/coc.0000000000000702

Subramaniam, R. M., Kurth, D. A., Waldrip, M. H. A., & Rybicki, F. J. (2019). American College of Radiology Appropriateness Criteria: Advancing Evidence-Based Imaging Practice. Seminars in Nuclear Medicine, 49(2), 161-165. doi: 10.1053/j.semnuclmed.2018.11.011

Rahmim, A., Bak-Fredslund, K. P., Ashrafinia, S., Lu, L., Schmidtlein, C. R., Subramaniam, R. M., … Munk, O. L. (2019). Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. European Journal of Radiology, 113, 101-109. doi: 10.1016/j.ejrad.2019.02.006

You, H., Xi, Y., Moore, W., Sher, D., Sanli, Y., & Subramaniam, R. M. (2019). Timing and impact of posttreatment PET/CT after first 6 months on patient management and outcomes in oropharyngeal squamous cell carcinoma. American Journal of Roentgenology, 212(5), 1142-1147. doi: 10.2214/AJR.18.20619

You, H., Sanli, Y., & Subramaniam, R. (2019). Impact of point-spread function reconstruction on 68Ga-DOTATATE PET/CT quantitative imaging parameters. American Journal of Roentgenology, 213(3), 683-688. doi: 10.2214/AJR.18.21067

Mirpour, S., Turkbey, E. B., Marashdeh, W., El Khouli, R., & Subramaniam, R. (2018). Impact of DAT-SPECT on management of patients suspected of parkinsonism. Clinical Nuclear Medicine, 43(10), 710-714. doi: 10.1097/RLU.0000000000002240

Mhlanga, J. C., Chirindel, A., Lodge, M. A., Wahl, R. L., & Subramaniam, R. M. (2018). Quantitative PET/CT in clinical practice: Assessing the agreement of PET tumor indices using different clinical reading platforms. Nuclear Medicine Communications, 39(2), 154-160. doi: 10.1097/MNM.0000000000000786

Savir-Baruch, B., Banks, K. P., McConathy, J. E., Molchanova-Cook, O. P., Parent, E. E., Takalkar, A., … Subramaniam, R. M., & Schuster, D. M. (2018). ACR-ACNM practice parameter for the performance of fluorine-18 fluciclovine-PET/CT for recurrent prostate cancer. Clinical Nuclear Medicine, 43(12), 909-917. doi: 10.1097/RLU.0000000000002310

Subramaniam, R. M., Bradshaw, M. L., Lewis, K., Pinho, D., Shah, C., & Walker, R. C. (2018). ACR practice parameter for the performance of gallium-68 DOTATATE PET/CT for neuroendocrine tumors. Clinical Nuclear Medicine, 43(12), 899-908. doi: 10.1097/RLU.0000000000002309

Gareen, I. F., Hillner, B. E., Hanna, L., Makineni, R., Duan, F., Shields, A. F., Subramaniam, R. M., & Siegel, B. A. (2018). Hospice admission and survival after 18 F-fluoride PET performed for evaluation of osseous metastatic disease in the national oncologic PET registry. Journal of Nuclear Medicine, 59(3), 427-433. doi: 10.2967/jnumed.117.205120

Acuff, S. N., Jackson, A. S., Subramaniam, R. M., & Osborne, D. (2018). Practical considerations for integrating PET/CT into radiation therapy planning. Journal of Nuclear Medicine Technology, 46(4), 343-348. doi: 10.2967/jnmt.118.209452

Hillner, B. E., Hanna, L., Makineni, R., Duan, F., Shields, A. F., Subramaniam, R. M., … Siegel, B. A. (2018). Intended versus inferred treatment after 18 F-fluoride PET performed for evaluation of osseous metastatic disease in the national oncologic PET registry. Journal of Nuclear Medicine, 59(3), 421-426. doi: 10.2967/jnumed.117.205047

Kandathil, A., Kay, F. U., Butt, Y. M., Wachsmann, J. W., & Subramaniam, R. M. (2018). Role of FDG PET/CT in the eighth edition of TNM staging of non– Small cell lung cancer. Radiographics, 38(7), 2134-2149. doi: 10.1148/rg.2018180060

Subramaniam, R. M. (2017). Precision medicine and PET/computed tomography: Challenges and implementation. PET Clinics, 12(1), 1-5. doi: 10.1016/j.cpet.2016.08.010

Mena, E., Thippsandra, S., Yanamadala, A., Redy, S., Pattanayak, P., & Subramaniam, R. M. (2017). Molecular imaging and precision medicine in head and neck cancer. PET Clinics, 12(1), 7-25. doi: 10.1016/j.cpet.2016.08.009

Mena, E., Taghipour, M., Sheikhbahaei, S., Jha, A. K., Rahmim, A., Solnes, L., & Subramaniam, R. M. (2017). Value of intratumoral metabolic heterogeneity and quantitative 18F-FDG PET/CT parameters to predict prognosis in patients with HPV-positive primary oropharyngeal squamous cell carcinoma. Clinical Nuclear Medicine, 42(5), e227-e234. doi: 10.1097/RLU.0000000000001578

Subramaniam, R. M., Frey, K. A., Hunt, C. H., Mercier, Jr, G. A., Solnes, L. B., Colletti, P. M., … Williams, H. T. (2017). ACR-ACNM practice parameter for the performance of dopamine transporter (DaT) single photon emission computed tomography (SPECT) imaging for movement disorders. Clinical Nuclear Medicine, 42(11), 847-852. doi: 10.1097/RLU.0000000000001815

Taghipour, M., Marcus, C., Sheikhbahaei, S., Mena, E., Prasad, S., . . ., & Subramaniam, R. M. (2017). Clinical indications and impact on management: Fourth and subsequent posttherapy follow-up 18F-FDG PET/CT scans in oncology patients. Journal of Nuclear Medicine, 58(5), 737-743. doi: 10.2967/jnumed.116.183111

Mena, E., Sheikhbahaei, S., Taghipour, M., Jha, A. K., Vicente, E., Xiao, J., & Subramaniam, R. M. (2017). 18F-FDG PET/CT metabolic tumor volume and intratumoral heterogeneity in pancreatic adenocarcinomas: Impact of dual-time point and segmentation methods. Clinical Nuclear Medicine, 42(1), e16-e21. doi: 10.1097/RLU.0000000000001446

Sheikhbahaei, S., Mena, E., Pattanayak, P., Taghipour, M., Solnes, L. B., & Subramaniam, R. M. (2017). Molecular imaging and precision medicine: PET/computed tomography and therapy response assessment in oncology. PET Clinics, 12(1), 105-118. doi: 10.1016/j.cpet.2016.08.002

Sanli, Y., Yilmaz, E., & Subramaniam, R. M. (2017). Precision medicine and PET–computed tomography in pediatric malignancies. PET Clinics, 12(4), 423-435. doi: 10.1016/j.cpet.2017.05.009

Marcus, C., & Subramaniam, R. M. (2017). PET/computed tomography and precision medicine: Gastric cancer. PET Clinics, 12(4), 437-447. doi: 10.1016/j.cpet.2017.05.004

Mena, E., Sanli, Y., Marcus, C., & Subramaniam, R. M. (2017). Precision medicine and PET/computed tomography in melanoma. PET Clinics, 12(4), 449-458. doi: 10.1016/j.cpet.2017.05.002

Sheikhbahaei, S., Ahn, S. J., Young, B., Taghipour, M., Marcus, C., & Subramaniam, R. M. (2017). Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer. Nuclear Medicine Communications, 38(8), 720-725. doi: 10.1097/MNM.0000000000000707

Marcus, C., & Subramaniam, R. M. (2017). PET/computed tomography and precision medicine: Musculoskeletal sarcoma. PET Clinics, 12(4), 475-488. doi: 10.1016/j.cpet.2017.05.005

Goel, R., Subramaniam, R. M., & Wachsmann, J. W. (2017). PET/computed tomography scanning and precision medicine: Esophageal cancer. PET Clinics, 12(4), 373-391. doi: 10.1016/j.cpet.2017.05.001

Soltani, M., Sefidgar, M., Bazmara, H., Casey, M. E., Subramaniam, R. M., Wahl, R. L., & Rahmim, A. (2017). Spatiotemporal distribution modeling of PET tracer uptake in solid tumors. Annals of Nuclear Medicine, 31, 109-124. doi: 10.1007/s12149-016-1141-4

Jha, A. K., Mena, E., Caffo, B. S., Ashrafinia, S., Rahmim, A., Grey, E. C., & Subramaniam, R. M. (2017). Practical no-gold-standard evaluation framework for quantitative imaging methods: Application to lesion segmentation in positron emission tomography. Journal of Medical Imaging, 4(1), 011011. doi: 10.1117/1.JMI.4.1.011011

Dako, F., Wray, R., Awan, O., & Subramaniam, R. M. (2017). Adapting a standardized, industry-proven tool to measure patients' perceptions of quality at the point of care in a PET/CT center. Journal of Nuclear Medicine Technology, 45(4), 285-289. doi: 10.2967/jnmt.117.196170

Subramaniam, R. M., Janowitz, W. R., Johnson, G. B., Lodge, M. A., Parisi, M. T., Ferguson, M. R., … Gupta, N. K. (2017). ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography: Computed tomography (PET/CT) imaging. Clinical Nuclear Medicine, 42(12), 918-927. doi: 10.1097/RLU.0000000000001827

Pinho, D. F., & Subramaniam, R. M. (2017). PET–computed tomography and precision medicine in pancreatic adenocarcinoma and pancreatic neuroendocrine tumors. PET Clinics, 12(4), 407-421. doi: 10.1016/j.cpet.2017.05.003

Taghipour, M., Mena, E., Kruse, M. J., Sheikhbahaei, S., & Subramaniam, R. M. (2017). Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: Comparative effectiveness study. Nuclear Medicine Communications, 38(3), 250-258. doi: 10.1097/MNM.0000000000000639

Taghipour, M., Sheikhbahaei, S., Wray, R., Agrawal, N., Richmon, J., Kang, H., & Subramaniam, R. M. (2016). FDG PET/CT in patients with head and neck squamous cell carcinoma after primary surgical resection with or without chemoradiation therapy. American Journal of Roentgenology, 206(5), 1093-1100. doi: 10.2214/AJR.15.15604

Taghipour, M., Marcus, C., Jones, S., Sarangi, R., Trahan, T. J., & Subramaniam, R. M. (2016). The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma. Nuclear Medicine Communications, 37(7), 699-704. doi: 10.1097/MNM.0000000000000504

Marcus, C., Wray, R., Taghipour, M., Marashdeh, W., Ahn, S. J., Mena, E., & Subramaniam, R. M. (2016). Value of quantitative FDG PET/CT volumetric biomarkers in recurrent colorectal cancer patient survival. American Journal of Roentgenology, 207(2), 257-265. doi: 10.2214/AJR.15.15806

Sheikhbahaei, S., Marcus, C., Wray, R., Rahmim, A., Lodge, M. A., & Subramaniam, R. M. (2016). Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors. Nuclear Medicine Communications, 37(3), 288-296. doi: 10.1097/MNM.0000000000000445

Taghipour, M., Marcus, C., Nunna, P., & Subramaniam, R. M. (2016). Follow-up FDG PET/CT in patients with non-Hodgkin lymphoma: Value to clinical assessment and patient management. Clinical Nuclear Medicine, 41(2), e93-e97. doi: 10.1097/RLU.0000000000001034

Mena, E., Taghipour, M., Sheikhbahaei, S., Mirpour, S., Xiao, J., & Subramaniam, R. M. (2016). 18F-FDG PET/CT and melanoma: Value of fourth and subsequent posttherapy follow-up scans for patient management. Clinical Nuclear Medicine, 41(9), e403-e409. doi: 10.1097/RLU.0000000000001275

Sheikhbahaei, S., Wray, R., Young, B., Mena, E., Taghipour, M., Rahmim, A., & Subramaniam, R. M. (2016). 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: Impact on management and utilization of quantitative parameters for patient survival prediction. Nuclear Medicine Communications, 37(3), 231-238. doi: 10.1097/MNM.0000000000000436

Nunna, P., Sheikhbahaei, S., Ahn, S., Young, B., & Subramaniam, R. M. (2016). The role of positron emission tomography/computed tomography in management and prediction of survival in pancreatic cancer. Journal of Computer Assisted Tomography, 40(1), 142-151. doi: 10.1097/RCT.0000000000000323

Mena, E., Yanamadala, A., Cheng, G., & Subramaniam, R. M. (2016). The current and evolving role of PET in personalized management of lung cancer. PET Clinics, 11(3), 243-259. doi: 10.1016/j.cpet.2016.02.010

Sheikhbahaei, S., Trahan, T. J., Xiao, J., Taghipour, M., Mena, E., Connolly, R. M., & Subramaniam, R. M. (2016). FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patientswith breast cancer: A meta-analysis of diagnostic accuracy studies. Oncologist, 21(8), 931-939. doi: 10.1634/theoncologist.2015-0353

Subramaniam, R. M., Shields, A. F., Sachedina, A., Hanna, L., Duan, F., Siegel, B. A., & Hillner, B. E. (2016). Impact on patientmanagement of [18F]-fluorodeoxyglucose-positron emission tomography (PET)used for cancer diagnosis: Analysis ofdata from the national oncologic PET registry. Oncologist, 21(9), 1079-1084. doi: 10.1634/theoncologist.2015-0364

Taghipour, M., Wray, R., Sheikhbahaei, S., Wright, J. L., & Subramaniam, R. M. (2016). FDG avidity and tumor burden: Survival outcomes for patients with recurrent breast cancer. American Journal of Roentgenology, 206(4), 846-855. doi: 10.2214/AJR.15.15106

Fakhry, C., Qualliotine, J. R., Zhang, Z., Agrawal, N., Gaykalova, D. A., Bishop, J. A., Subramaniam, R. M., … Viscidi, R. P. (2016). Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer. Cancer Prevention Research, 9(2), 135-141. doi: 10.1158/1940-6207.CAPR-15-0299

Wray, R., Sheikhbahaei, S., Marcus, C., Zan, E., Ferraro, R., Rahmim, A., & Subramaniam, R. M. (2016). Therapy response assessment and patient outcomes in head and neck squamous cell carcinoma: FDG PET Hopkins criteria versus residual neck node size and morphologic features. American Journal of Roentgenology, 207(3), 641-647. doi: 10.2214/AJR.15.15730

Sheikhbahaei, S., Mena, E., Marcus, C., Wray, R., Taghipour, M., & Subramaniam, R. M. (2016). 18F-FDG PET/CT: Therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients. Journal of Nuclear Medicine, 57(6), 855-860. doi: 10.2967/jnumed.115.165480

Taghipour, M., Sheikhbahaei, S., Trahan, T. J., & Subramaniam, R. M. (2016). Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer. Nuclear Medicine Communications, 37(6), 602-608. doi: 10.1097/MNM.0000000000000491

Wippold, II, F. J., Brown, D. C., Broderick, D. F., Burns, J., Corey, A. S., Deshmukh, T. K., … Subramaniam, R. M. (2015). ACR appropriateness criteria dementia and movement disorders. Journal of the American College of Radiology, 12(1), 19-28. doi: 10.1016/j.jacr.2014.09.025

Taghipour, M., Marcus, C., Califano, J., Fakhry, C., & Subramaniam, R. M. (2015). The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma. Journal of Medical Imaging & Radiation Oncology, 59(6), 681-686. doi: 10.1111/1754-9485.12354

Zegers, C. M. L., van Elmpt, W., Szardenings, K., Kolb, H., Waxman, A., Subramaniam, R. M., … Chien, D. (2015). Repeatability of hypoxia PET imaging using [18F]HX4 in lung and head and neck cancer patients: Aprospective multicenter trial. European Journal of Nuclear Medicine & Molecular Imaging, 42(12), 1840-1849. doi: 10.1007/s00259-015-3100-z

Marcus, C., Paidpally, V., Antoniou, A., Zaheer, A., Wahl, R. L., & Subramaniam, R. M. (2015). 18F-FDG PET/CT and lung cancer: Value of fourth and subsequent posttherapy follow-up scans for patient management. Journal of Nuclear Medicine, 56(2), 204-208. doi: 10.2967/jnumed.114.147884

Sheikhbahaei, S., Marcus, C., & Subramaniam, R. M. (2015). 18F FDG PET/CT and head and neck cancer: Patient management and outcomes. PET Clinics, 10(2), 125-145. doi: 10.1016/j.cpet.2014.12.001

Wray, R., Solnes, L., Mena, E., Meoded, A., & Subramaniam, R. M. (2015). 18F-flourodeoxy-glucose PET/computed tomography in brain tumors: Value to patient management and survival outcomes. PET Clinics, 10(3), 423-430. doi: 10.1016/j.cpet.2015.03.011

Tahari, A. K., Paidpally, V., Chirindel, A., Wahl, R. L., & Subramaniam, R. M. (2015). Two-time-point FDG PET/CT: Liver SULmean repeatability. American Journal of Roentgenology, 204(2), 402-407. doi: 10.2214/AJR.14.12719

Ferraro, R., Agarwal, A., Martin-Macintosh, E. L., Peller, J. R., & Subramaniam, R. M. (2015). MR imaging and PET/CT in diagnosis and management of multiple myeloma. Radiographics, 35(2), 438-454. doi: 10.1148/rg.352140112

Kwee, R. M., Marcus, C., Sheikhbahaei, S., & Subramaniam, R. M. (2015). PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer. PET Clinics, 10(2), 197-205. doi: 10.1016/j.cpet.2014.12.003

Marcus, C., Antoniou, A., Rahmim, A., Ladenson, P., & Subramaniam, R. M. (2015). Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival. Journal of Medical Imaging & Radiation Oncology, 59(3), 281-288. doi: 10.1111/1754-9485.12286

Yu, J.-P. J., Kansagra, A. P., Thaker, A., Colucci, A., Sherry, S. J., & Subramaniam, R. M. (2015). Building for tomorrow today: Opportunities and directions in radiology resident research. Academic Radiology, 22(1), 50-57. doi: 10.1016/j.acra.2014.08.012

Sheikhbahaei, S., Marcus, C., Hafezi-Nejad, N., Taghipour, M., & Subramaniam, R. M. (2015). Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas. PET Clinics, 10(3), 375-393. doi: 10.1016/j.cpet.2015.03.003

Weber, W. A., Gatsonis, C. A., Mozley, P. D., Shields, A. F., Govindan, R., Torigian, D. A., … Subramaniam, R. M., for the ACRIN 6678 and MK-0646-008 Research teams. (2015). Repeatability of 18F-FDG PET/CT in advanced non-small cell lung cancer: Prospective assessment in 2 multicenter trials. Journal of Nuclear Medicine, 56(8), 1137-1143. doi: 10.2967/jnumed.114.147728

Perng, P., Marcus, C., & Subramaniam, R. M. (2015). 18F-FDG PET/CT and melanoma: Staging, immune modulation and mutation-targeted therapy assessment, and prognosis. American Journal of Roentgenology, 205(2), 259-270. doi: 10.2214/AJR.14.13575

Marcus, C., Marashdeh, W., Ahn, S. J., Taghipour, M., & Subramaniam, R. M. (2015). 18F-FDG PET/CT and colorectal cancer: Value of fourth and subsequent posttherapy follow-up scans for patient management. Journal of Nuclear Medicine, 56(7), 989-994. doi: 10.2967/jnumed.115.156240

Coquia, S. F., Hamper, U. M., Holman, M. E., DeJong, M. R., Subramaniam, R. M., Aygun, N., & Fakhry, C. (2015). Visualization of the oropharynx with transcervical ultrasound. American Journal of Roentgenology, 205(6), 1288-1294. doi: 10.2214/AJR.15.14299

Parikh, U., Marcus, C., Sarangi, R., Taghipour, M., & Subramaniam, R. M. (2015). FDG PET/CT in pancreatic and hepatobiliary carcinomas: Value to patient management and patient outcomes. PET Clinics, 10(3), 327-343. doi: 10.1016/j.cpet.2015.03.001

Ciarallo, A., Marcus, C., Taghipour, M., & Subramaniam, R. M. (2015). Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer. PET Clinics, 10(2), 265-278. doi: 10.1016/j.cpet.2014.12.009

Abramson, R. G., Burton, K. R., Yu, J.-P. J., Scalzetti, E. M., Yankeelov, T. E., Rosenkrantz, A. B., … Subramaniam, R. M. (2015). Methods and challenges in quantitative imaging biomarker development. Academic Radiology, 22(1), 25-32. doi: 10.1016/j.acra.2014.09.001

Sheikhbahaei, S., Jin Ahn, S., Moriarty, E., Kang, H., Fakhry, C., & Subramaniam, R. M. (2015). Intratherapy or posttherapy FDG PET or FDG PET/CT for patients with head and neck cancer: A Systematic review and metaanalysis of prognostic studies. American Journal of Roentgenology, 205(5), 1103-1113. doi: 10.2214/AJR.15.14647

Chirindel, A., Alluri, K., Tahari, A. K., Chaudhry,, M., Wahl, R. L., Lodge, M. A., & Subramaniam, R. M. (2015). Liver standardized uptake value corrected for lean body mass at FDG PET/CT: Effect of FDG uptake time. Clinical Nuclear Medicine, 40(1), e17-e22. doi: 10.1097/RLU.0000000000000446

Sheikhbahaei, S., Taghipour, M., Ahmad, R., Fakhry, C., Kiess, A. P., Chung, C. H., & Subramaniam, R. M. (2015). Diagnostic accuracy of follow-up FDG PET or PET/CT in patients with head and neck cancer after definitive treatment: A systematic review and meta-analysis. American Journal of Roentgenology, 205(3), 629-639. doi: 10.2214/AJR.14.14166

Rahmim, A., Schmidtlein, C. R., Jackson, A., Sheikhbahaei, S., Marcus, C., Ashrafinia, S., … Subramaniam, R. M. (2015). A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. Physics in Medicine & Biology, 61(1), 227-242. doi: 10.1088/0031-9155/61/1/227

Chirindel, A., Alluri, K. C., Chaudhry, M. A., Wahl, R. L., Pawlik, T. M., Herman, J. M., & Subramaniam, R. M. (2015). Prognostic value of FDG PET/CT-derived parameters in pancreatic adenocarcinoma at initial PET/CT staging. American Journal of Roentgenology, 204(5), 1093-1099. doi: 10.2214/AJR.14.13156

Chung, C. H., Guthrie, V. B., Masica, D. L., Tokheim, C., Kang, H., Richmon, J., … Subramaniam, R. M., … Bishop, J. A. (2015). Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. Annals of Oncology, 26(6), 1216-1223. doi: 10.1093/annonc/mdv109

Karantanis, D., Kalkanis, D., Czernin, J., Herrmann, K., Pomykala, K. L., Bogsrud, T. V., Subramaniam, R. M., … Allen-Auerbach, M. (2014). Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: A survey of referring physicians. Journal of Nuclear Medicine, 55(12), 1925-1929. doi: 10.2967/jnumed.114.145607

Marcus, C., Ciarallo, A., Tahari, A. K., Mena, E., Koch, W., Wahl, R. L., … Subramaniam, R. M. (2014). Head and neck PET/CT: Therapy response interpretation criteria (Hopkins criteria): Interreader reliability, accuracy, and survival outcomes. Journal of Nuclear Medicine, 55(9), 1411-1416. doi: 10.2967/jnumed.113.136796

Paidpally, V., Mercier, G., Shah, B. A., Senthamizhchelvan, S., & Subramaniam, R. M. (2014). Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors. American Journal of Roentgenology, 202(2), 406-412. doi: 10.2214/AJR.13.10841

Subramaniam, R. M., Alluri, K. C., Tahari, A. K., Aygun, N., & Quon, H. (2014). PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: Evolving clinical imaging paradigm. Journal of Nuclear Medicine, 55(3), 431-438. doi: 10.2967/jnumed.113.125542

Tahari, A. K., Alluri, K. C., Quon, H., Koch, W., Wahl, R. L., & Subramaniam, R. M. (2014). FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: Characteristics of human papillomavirus-positive and -negative tumors. Clinical Nuclear Medicine, 39(3), 225-231. doi: 10.1097/RLU.0000000000000255

Alluri, K. C., Tahari, A. K., Wahl, R. L., Koch, W., Chung, C. H., & Subramaniam, R. M. (2014). Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. American Journal of Roentgenology, 203(4), 897-903. doi: 10.2214/AJR.14.12497

Antoniou, A. J., Marcus, C., Tahari, A. K., Wahl, R. L., & Subramaniam, R. M. (2014). Follow-up or surveillance 18F-FDG PET/CT and survival outcome in lung cancer patients. Journal of Nuclear Medicine, 55(7), 1062-1068. doi: 10.2967/jnumed.113.136770

Romesser, P. B., Qureshi, M. M., Subramaniam, R. M., Sakai, O., Jalisi, S., & Truong, M. T. (2014). A prognostic volumetric threshold of gross tumor volume in head and neck cancer patients treated with radiotherapy. American Journal of Clinical Oncology, 37(2), 154-161. doi: 10.1097/COC.0b013e31826e04d6

Yu, J., Cooley, T., Truong, M.-T., Mercier, G., & Subramaniam, R. M. (2014). Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: Value of FDG volumetric imaging parameters. Journal of Medical Imaging & Radiation Oncology, 58(1), 18-24. doi: 10.1111/1754-9485.12081

Sridhar, P., Mercier, G., Tan, J., Truong, M. T., Daly, B., & Subramaniam, R. M. (2014). FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors. American Journal of Roentgenology, 202(5), 1114-1119. doi: 10.2214/AJR.13.11456

Marcus, C., Whitworth, P. W., Surasi, D. S., Pai, S. I., & Subramaniam, R. M. (2014). PET/CT in the management of thyroid cancers. American Journal of Roentgenology, 202(6), 1316-1329. doi: 10.2214/AJR.13.11673

Paidpally, V., Chirindel, A., Chung, C. H., Richmon, J., Koch, W., Quon, H., & Subramaniam, R. M. (2014). FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. American Journal of Roentgenology, 203(2), W139-W145. doi: 10.2214/AJR.13.11654

Marcus, C., Mena, E., & Subramaniam, R. M. (2014). Brain PET in the diagnosis of Alzheimer's disease. Clinical Nuclear Medicine, 39(10), e413-e426. doi: 10.1097/RLU.0000000000000547

Subramaniam, R. M., Agarwal, A., Colucci, A., Ferraro, R., Paidpally, V., & Mercier, G. (2013). Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone CT and MRI in the management of head and neck cancer patients. Clinical Nuclear Medicine, 38(10), 790-794. doi: 10.1097/RLU.0b013e31829f8ca5

Shilpa Surasi, D., Peller, P. J., Szabo, Z., Mercier, G., & Subramaniam, R. M. (2013). Dopamine transporter SPECT imaging in parkinson disease and dementia. PET Clinics, 8(4), 459-467. doi: 10.1016/j.cpet.2013.08.006

Whitworth, P. W., Agarwal, A., Colucci, A., Sherry, S. J., & Subramaniam, R. M. (2013). Radiology research and medical students. Academic Radiology, 20(12), 1506-1510. doi: 10.1016/j.acra.2013.09.013

Paidpally, V., Tahari, A. K., Lam, S., Alluri, K., Marur, S., Koch, W., … Subramaniam, R. M. (2013). Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: A retrospective analysis with follow-up for 12 years. Journal of Nuclear Medicine, 54(12), 2039-2045. doi: 10.2967/jnumed.113.121285

Davison, J., Mercier, G., Russo, G., & Subramaniam, R. M. (2013). PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma. American Journal of Roentgenology, 200(3), 635-640. doi: 10.2214/AJR.12.9138

Malladi, A., Viner, M., Jackson, T., Mercier, G., & Subramaniam, R. M. (2013). PET/CT mediastinal and liver FDG uptake: Effects of biological and procedural factors. Journal of Medical Imaging & Radiation Oncology, 57(2), 169-175. doi: 10.1111/1754-9485.12015

Viner, M., Mercier, G., Hao, F., Malladi, A., & Subramaniam, R. M. (2013). Liver SULmean at FDG PET/CT: Interreader agreement and impact of placement of volume of interest. Radiology, 267(2), 596-601. doi: 10.1148/radiol.12121385

Ebright, M. I., Russo, G. A., Gupta, A., Subramaniam, R. M., Fernando, H. C., & Kachnic, L. A. (2013). Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. Journal of Thoracic & Cardiovascular Surgery, 145(3), 709-715. doi: 10.1016/j.jtcvs.2012.12.024

Broski, S. M., Hunt, C. H., Johnson, G. B., Subramaniam, R. M., & Peller, P. J. (2012). The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. Journal of Nuclear Medicine, 53(8), 1200-1206. doi: 10.2967/jnumed.112.102897

Karantanis, D., Kalkanis, D., Allen-Auerbach, M., Velde Bogsrud, T., Subramaniam, R. M., Danielson, A., … Czernin, J. (2012). Oncologic 18F-FDG PET/CT: Referring physicians' point of view. Journal of Nuclear Medicine, 53(10), 1499-1505. doi: 10.2967/jnumed.111.102228

Shah, B., Srivastava, N., Hirsch, A. E., Mercier, G., & Subramaniam, R. M. (2012). Intra-reader reliability of FDG PET volumetric tumor parameters: Effects of primary tumor size and segmentation methods. Annals of Nuclear Medicine, 26(9), 707-714. doi: 10.1007/s12149-012-0630-3

Romesser, P. B., Qureshi, M. M., Shah, B. A., Chatburn, L. T., Jalisi, S., Devaiah, A. K., Subramaniam, R. M., & Truong, M. T. (2012). Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy. Annals of Nuclear Medicine, 26(7), 527-534. doi: 10.1007/s12149-012-0604-5

More publications...